IMPACT OF KIDNEY PALLIATIVE CARE ON SYMPTOM BURDEN IN ADVANCED CKD AND ESKD: A COHORT STUDY FROM MALAYSIA

Certificate Output Instructions

For best output, select "Paper Size" as "A4" and "Margin" as "0" or "None".

To save or print to PDF, please select Print Destination > Save as PDF, enable Background Graphics under "More Settings", then click "Save".

Presented the abstract " "
(Abstract co-author(s): )

Back

E-Poster Presentation

During the congress, E-Posters will be accessible to all participants on the congress website 24/7, as well as in the E-poster stations in the congress center.

Preparing your E-Poster

Please review the E-Poster format requirements carefully when preparing your E-Poster. Should your E-Poster not meet the mentioned requirements, it may not be displayed as described above.

E-Poster Submission Deadline

Please prepare and upload your E-Poster no later than March 14, 2026 11.59PM CET. After this date, you will no longer be able to prepare and upload your E-poster and it will not be displayed and accessible on the congress website.

E-Poster Format Requirements

PDF file
Layout: Portrait (vertical orientation)
One page only (Dim A4: 210 x 297mm or PPT)
E-Poster can be prepared in PowerPoint (one (1) PowerPoint slide) but must be saved and submitted as PDF file.
File Size: Maximum file size is 2 Megabytes (2 MB)
No hyperlinks, animated images, animations, and slide transitions
Language: English
Include your abstract number
E-posters can include QR codes, tables and photos

E-Poster

Abstract Title *

IMPACT OF KIDNEY PALLIATIVE CARE ON SYMPTOM BURDEN IN ADVANCED CKD AND ESKD: A COHORT STUDY FROM MALAYSIA

Please follow the instructions below to input your abstract title.

Abstract titles should be brief and reflect the content of the abstract.

The title will not be accepted if it exceeds 25 words.
Type in CAPITAL LETTERS.
Lowercase may be used for abbreviations only, for example, mRNA.

Co-author 1

Agni Nhirmal Kumar Sugurmar agninhirmal@yahoo.com Hospital Tuanku Jaafar Seremban Nephrology Seremban Malaysia *

Co-author 2

Asiah Usamah asiahusamah@gmail.com Hospital Tuanku Jaafar Seremban Nephrology Seremban Malaysia -

Co-author 3

Anila Perumal sagi21ster@gmail.com Hospital Tuanku Jaafar Seremban Palliative Seremban Malaysia -

Co-author 4

Iris Chung arisa_ko@hotmail.com Hospital Tuanku Jaafar Seremban Palliative Seremban Malaysia -

Co-author 5

Brian Joe Anthony brianjoe1983@hotmail.com Hospital Tuanku Ampuan Najihah Nephrology Kuala Pilah Malaysia -

Co-author 6

Muhd Zulfadli Hafiz Ismail m.zulfadli@moh.gov.my National Institutes of Health Sector of Biostatistics and Data Repository Shah Alam Malaysia -

Co-author 7

Lily Mushahar lilymushahar@gmail.com Hospital Tuanku Jaafar Seremban Nephrology Seremban Malaysia -

Co-author 8

Co-author 9

Co-author 10

Co-author 11

Co-author 12

Co-author 13

Co-author 14

Co-author 15

Introduction

Palliative care offers patient-centred health services aimed at improving the quality of life for both patients and their caregivers. Patients with advanced chronic kidney disease (CKD) and end-stage kidney disease (ESKD) often experience a high symptom burden, making symptom alleviation a central focus of care.

Methods

We conducted a retrospective cohort study of inpatients referred to the kidney palliative care team in 2023 in Negeri Sembilan, Malaysia. Of the 92 patients with baseline Edmonton Symptom Assessment System (ESAS) scores recorded upon admission, 44 had follow-up ESAS scores available for analysis. Data normality was tested using the Shapiro–Wilk test. Paired t-tests were used for normally distributed symptoms, and Wilcoxon signed-rank tests for non-normal data.

Results

Kidney palliative care played a vital role in end-of-life support, with most patients managed conservatively and passing away at home—reflecting strong community and family involvement. Among the 44 patients who completed both baseline and follow-up ESAS assessments, significant improvements were observed in pain and nausea, while drowsiness worsened, likely due to treatment-related effects. These findings offer important insights into symptom progression and management within kidney palliative care.

Kewords